FTI
69
-7
KLAC
56
-3
PCG
74
-6
STX
53
-4
XOM
48
3
AMAT
49
-3
GE
85
3
NUE
50
3
VNO
59
3
SO
64
-2
DLTR
31
3
VRTX
56
-4
PX
52
-3
JPM
53
-2
NFLX
55
-3
PPL
60
-7
WDC
49
-3
AVY
54
-14
MA
65
-4
CRM
50
-5
FTI
69
-7
KLAC
56
-3
PCG
74
-6
STX
53
-4
XOM
48
3
AMAT
49
-3
GE
85
3
NUE
50
3
VNO
59
3
SO
64
-2
DLTR
31
3
VRTX
56
-4
PX
52
-3
JPM
53
-2
NFLX
55
-3
PPL
60
-7
WDC
49
-3
AVY
54
-14
MA
65
-4
CRM
50
-5
Financhill
Back

Editas Medicine Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

EDIT
Editas Medicine

Last Price:
3.92
Seasonality Move:
2.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Editas Medicine Price Quote

$3.92
+0.05 (+1.29%)
(Updated: September 19, 2024 at 5:15 PM ET)

Editas Medicine Key Stats

Sell
40
Editas Medicine (EDIT) is a Sell
Day range:
$3.86 - $4.12
52-week range:
$3.40 - $11.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.73
P/B ratio:
1.38%
Volume:
2.6M
Avg. volume:
1.7M
1-year change:
-51.69%
Market cap:
$319.2M
Revenue:
$78.1M
EPS:
$-2.36

How Much Does Editas Medicine Make?

Is Editas Medicine Growing As A Company?

  • What Is Editas Medicine's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.82%
  • What Is Editas Medicine's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Editas Medicine Stock Price Performance

  • Did Editas Medicine Stock Go Up Last Month?
    Editas Medicine share price went down by -3.25% last month
  • Did EDIT's Share Price Rise Over The Last Year?
    EDIT share price fell by -51.69% over the past 1 year

What Is Editas Medicine 52-Week High & Low?

Editas Medicine Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Editas Medicine?

  • How Much Debt Does Editas Medicine Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Editas Medicine Have?
    Cash and short term investments quarterly total is $279.1M
  • What Is Editas Medicine’s Book Value Per Share?
    Book value per share is 2.81

Is Editas Medicine Cash Flow Positive?

  • What Is EDIT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$164.6M
  • What Is Editas Medicine’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1M
  • What Is Editas Medicine’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $7.2M

Editas Medicine Return On Invested Capital

  • Is Management Doing A Good Job?
    EDIT return on invested capital is -59.13%
  • What Is Editas Medicine Return On Assets?
    ROA measures how assets are converting to revenues and is -40.8%
  • What Is EDIT Return On Equity?
    ROE is a measure of profitability and is -59.13%

Editas Medicine Earnings Date & Stock Price

Editas Medicine Competitors

  • Who Are Editas Medicine's Competitors?
    Below is a list of companies who compete with Editas Medicine or are related in some way:
    • Biogen Inc (BIIB)
    • Moderna Inc (MRNA)
    • Intellia Therapeutics Inc (NTLA)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Vertex Pharmaceuticals Inc (VRTX)

Editas Medicine Dividend Yield

Editas Medicine Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -14.77%
Revenue: -82.23% -87.62%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 13.53
Upside from Last Price: 249.7%

Major Shareholders

  • How many EDIT shares are owned by institutional investors?
    81.5M EDIT shares are owned by institutional investors
  • How many EDIT shares are owned by insiders?
    3M EDIT shares are owned by insiders